person · Reporting owner
D'Alessio Lorraine Pamela
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL HOLDINGS CORP.AMIH · Entity 114347 | Director | January 13, 2022 | January 20, 2022 |
| MANGOCEUTICALS, INC.MGRX · Entity 8073 | Director | September 09, 2025 | September 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL HOLDINGS CORP.
Report date January 13, 2022 · Filed January 20, 2022
This filing explicitly reported no securities owned.
MANGOCEUTICALS, INC.
Report date September 09, 2025 · Filed September 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 136,667 |
Reported balance
After 2025-09-09 transaction · row 1
1 source rowRow 1 · 2025-09-09 · Grant · Acquired 100,000 · Balance 136,667 F1: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2025 Filed Sep 12, 2025 16:57 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-027216 · ownership.xml · nonDerivative · entry 1 D'Alessio Lorraine Pamela · CIK 0001905593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,667 F1 · kind: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003874 · ownership.xml · nonDerivative · entry 1 D'Alessio Lorraine Pamela · CIK 0001905593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,667 F1 · kind: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 17:15 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022804 · ownership.xml · nonDerivative · entry 1 D'Alessio Lorraine Pamela · CIK 0001905593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 F1 · kind: Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.